{"grounding": "Apicomplexan parasites constitute more than 6,000 species infecting a wide range of hosts. These include important pathogens such as those causing malaria and toxoplasmosis. Their evolutionary emergence coincided with the dawn of animals. Mitochondrial genomes of apicomplexan parasites have undergone dramatic reduction in their coding capacity, with genes for only three proteins and ribosomal RNA genes present in scrambled fragments originating from both strands. Different branches of the apicomplexans have undergone rearrangements of these genes, with Toxoplasma having massive variations in gene arrangements spread over multiple copies. The vast evolutionary distance between the parasite and the host mitochondria has been exploited for the development of antiparasitic drugs, especially those used to treat malaria, wherein inhibition of the parasite mitochondrial respiratory chain is selectively targeted with little toxicity to the host mitochondria. We describe additional unique characteristics of the parasite mitochondria that are being investigated and provide greater insights into these deep-branching eukaryotic pathogens.", "generated_text": "Apicomplexan parasites, including Plasmodium and Toxoplasma, possess mitochondria with unique structural and functional properties that distinguish them from those of their hosts. These mitochondria are characterized by a divergent ATP synthase and electron transport complexes, which are essential for the parasites' energy metabolism and survival. The atypical nature of these mitochondrial components presents a promising target for the development of novel antiparasitic drugs. Recent studies have elucidated the distinct architecture and biochemical pathways of apicomplexan mitochondria, revealing potential vulnerabilities that could be exploited therapeutically. The differences in mitochondrial function between apicomplexans and their hosts underscore the potential for selective drug targeting, minimizing host toxicity. Understanding the unique properties of apicomplexan mitochondria not only advances our knowledge of parasite biology but also aids in the design of innovative strategies to combat diseases such as malaria and toxoplasmosis. This research highlights the critical role of mitochondrial biology in the development of effective antiparasitic therapies.", "label": 1}